GERON CORP Related Party Transaction, Expenses from Transactions with Related Party
GERON CORP (GERN) reported Related Party Transaction, Expenses from Transactions with Related Party of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2013-03-15
- GERON CORP related party transaction, expenses from transactions with related party for the quarter ending 2011-12-31 was $0.00.
- GERON CORP related party transaction, expenses from transactions with related party for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
- GERON CORP related party transaction, expenses from transactions with related party for the quarter ending 2011-06-30 was $0.00, a 100.00% decline year-over-year.
- GERON CORP related party transaction, expenses from transactions with related party for the quarter ending 2010-12-31 was $0.00.
- GERON CORP related party transaction, expenses from transactions with related party for fiscal 2012 was $0.00.
- GERON CORP related party transaction, expenses from transactions with related party for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- GERON CORP related party transaction, expenses from transactions with related party for fiscal 2010 was $697.00K, a 60.28% decline from fiscal 2009.
- GERON CORP related party transaction, expenses from transactions with related party for fiscal 2009 was $1.75M.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month | Related Party Transaction, Expenses from Transactions with Related Party 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-15 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $0.00 derived: sum of 2 quarters · filed 2013-03-15 | $0.00 derived: sum of 3 quarters · filed 2013-03-15 | $0.00 10-K · filed 2013-03-15 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-03 | $0.00 derived: sum of 2 quarters · filed 2011-11-03 | $0.00 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-05 | $0.00 10-Q · filed 2011-08-05 | ||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $53.00K derived: sum of 2 quarters · filed 2013-03-15 | $370.00K derived: sum of 3 quarters · filed 2013-03-15 | $697.00K 10-K · filed 2013-03-15 |
| 2010-09-30 | $53.00K 10-Q · filed 2011-11-03 | $370.00K derived: sum of 2 quarters · filed 2011-11-03 | $697.00K 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $317.00K 10-Q · filed 2011-08-05 | $644.00K 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $1.75M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |